NCT01709487View on ClinicalTrials.gov

Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Ovarian CarcinomaFallopian Tube CarcinomaPrimary Peritoneal Carcinoma
Interventions
PROCEDURE

HIPEC

HIPEC with cisplatin 50 mg/m2 intraperitoneally at the end of surgery

Trial Locations (2)

1000

Institut Jules Bordet, Brussels

4000

Hopital de la Citadelle, Liège

Sponsors
All Listed Sponsors
lead

Jules Bordet Institute

OTHER